These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15162384)

  • 1. Evaluation of experimental strategies for the development of chiral chromatographic methods based on diastereomer formation.
    Srinivas NR
    Biomed Chromatogr; 2004 May; 18(4):207-33. PubMed ID: 15162384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous chiral analyses of multiple analytes: case studies, implications and method development considerations.
    Srinivas NR
    Biomed Chromatogr; 2004 Dec; 18(10):759-84. PubMed ID: 15584016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of chiral derivatizing agents in the high-performance liquid chromatographic separation of amino acid enantiomers: a review.
    Ilisz I; Berkecz R; Péter A
    J Pharm Biomed Anal; 2008 May; 47(1):1-15. PubMed ID: 18242036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetic data of racemic drugs obtained by the indirect method following precolumn diastereomer formation: is the influence of racemization during chiral derivatization significant?
    Srinivas NR
    Biomed Chromatogr; 2004 Jul; 18(6):343-9. PubMed ID: 15273974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gas chromatographic determination of enantiomers as diastereomers following pre-column derivatization and applications to pharmacokinetic studies: a review.
    Srinivas NR; Shyu WC; Barbhaiya RH
    Biomed Chromatogr; 1995; 9(1):1-9. PubMed ID: 7734927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of thin-layer chromatography in enantiomeric chiral analysis-an overview.
    Aboul-Enein HY; El-Awady MI; Heard CM; Nicholls PJ
    Biomed Chromatogr; 1999 Dec; 13(8):531-7. PubMed ID: 10611607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical and biomedical applications of enantioseparations using liquid chromatographic techniques.
    Haginaka J
    J Pharm Biomed Anal; 2002 Jan; 27(3-4):357-72. PubMed ID: 11755739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A screening study of ChirBase molecular database to explore the expanded chiral pool derived from the application of chiral chromatography.
    Piras P; Roussel C
    J Pharm Biomed Anal; 2008 Apr; 46(5):839-47. PubMed ID: 17942261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chiral metallocycles: rational synthesis and novel applications.
    Lee SJ; Lin W
    Acc Chem Res; 2008 Apr; 41(4):521-37. PubMed ID: 18271561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiomeric separation and determination of absolute stereochemistry of asymmetric molecules in drug discovery: building chiral technology toolboxes.
    McConnell O; Bach A; Balibar C; Byrne N; Cai Y; Carter G; Chlenov M; Di L; Fan K; Goljer I; He Y; Herold D; Kagan M; Kerns E; Koehn F; Kraml C; Marathias V; Marquez B; McDonald L; Nogle L; Petucci C; Schlingmann G; Tawa G; Tischler M; Williamson RT; Sutherland A; Watts W; Young M; Zhang MY; Zhang Y; Zhou D; Ho D
    Chirality; 2007 Sep; 19(9):658-82. PubMed ID: 17390370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States.
    Miller CP; Ullrich JW
    Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategic use of preparative chiral chromatography for the synthesis of a preclinical pharmaceutical candidate.
    Leonard WR; Henderson DW; Miller RA; Spencer GA; Sudah OS; Biba M; Welch CJ
    Chirality; 2007 Sep; 19(9):693-700. PubMed ID: 17354260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential properties of enantiomers of commercially available racemates.
    Gulati V
    J Indian Med Assoc; 2007 Apr; 105(4):173-4, 176. PubMed ID: 17822184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large scale chiral chromatography for the separation of an enantiomer to accelerate drug development.
    Hsu LC; Kim H; Yang X; Ross D
    Chirality; 2011 Apr; 23(4):361-6. PubMed ID: 21384442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chirality and drugs].
    Testa B; Reist M; Carrupt PA
    Ann Pharm Fr; 2000 Jul; 58(4):239-46. PubMed ID: 10915971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of direct assay of an aqueous formulation of a drug compound AZY by chiral supercritical fluid chromatography (SFC).
    Mukherjee PS
    J Pharm Biomed Anal; 2007 Jan; 43(2):464-70. PubMed ID: 16930907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologically active compounds in the environment and their chirality.
    Kasprzyk-Hordern B
    Chem Soc Rev; 2010 Nov; 39(11):4466-503. PubMed ID: 20852776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chirality and its implications in transdermal drug development.
    Reddy IK; Kommuru TR; Zaghloul AA; Khan MA
    Crit Rev Ther Drug Carrier Syst; 2000; 17(4):285-325. PubMed ID: 10958245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putting chirality to work: the strategy of chiral switches.
    Agranat I; Caner H; Caldwell J
    Nat Rev Drug Discov; 2002 Oct; 1(10):753-68. PubMed ID: 12360254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
    Srinivas NR
    Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.